logo.png
Enlivex Therapeutics Announces up to $15 Million Registered Direct Offering
28 mai 2024 08h12 HE | Enlivex Therapeutics Ltd
Single healthcare-focused institutional investor $5 million upfront with up to an additional $10 million of gross proceeds upon the exercise in full of clinical milestone-linked warrants ...
purple-logo2020.png
Purple Biotech Announces $5 Million Registered Direct Offering
17 oct. 2023 08h00 HE | Purple Biotech Ltd.
REHOVOT, Israel, Oct. 17, 2023 (GLOBE NEWSWIRE) --  Purple Biotech Ltd. (“Purple Biotech” or “the Company”) (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that...